NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Enfusion, Inc. (NYSE: ENFN) and its board of directors concerning the proposed acquisition of the company by Clearwater Analytics (NYSE: CWAN). Stockholders will receive a mix of shares of Clearwater Analytics common stock and cash worth $11.25 for each share of Enfusion stock that they hold. The transaction is valued at approximately $1.5 billion and is expected to close in the second quarter of ...

NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm by ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Enfusion, Inc. (NYSE: ENFN), relating to the proposed merger with Clearwater Analytics. Under the terms of the agreement, Enfusion shareholders will receive $5.85 per share in cash and $5.40 ...

Exhibit 2.1 EXECUTION COPY AGREEMENT AND PLAN OF MERGER by and among ENFUSION, INC., ENFUSION LTD. LLC, CLEARWATER ANALYTICS HOLDINGS, INC. POSEIDON ACQUIRER, INC. POSEIDON MERGER SUB I, INC. and POSEIDON MERGER SUB II, LLC JANUARY 10, 2025 TABLE OF CONTENTS | | Page | | --- | --- | | ARTICLE I DEFINITIONS | 2 | | Section 1.01 Definitions | 2 | | Section 1.02 Other Defined Terms | 20 | | Section 1.03 Other Definitional and Interpretative Provisions | 24 | | ARTICLE II THE MERGERS | 25 | | Section 2.01 The C ...

I wrote about Enfusion (NYSE: ENFN ) previously ( in August ) with a buy rating as management showed promising execution in its effort to move upmarket, and that growth should recover when theI am an individual investor that is now fully focus on managing my own capital that I have saved up over the years. My investing background spreads across a wide spectrum as I believe there are merits to each approach, for instance: Fundamental investing [Bottoms-up etc.], Technical investing [historical charts analysi ...

Table of Contents ENFN New York Stock Exchange UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40949 Enfusion, Inc. (Exact name of registrant as specified in its charter) ...

Enfusion, Inc. (NYSE:ENFN) Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET Company Participants Bill Wright - Head, IR Oleg Movchan - Chief Executive Officer Bradley Herring - Chief Financial Officer Neal Pawar - Chief Operating Officer Conference Call Participants Michael Infante - Morgan Stanley Dylan Becker - William Blair Parker Lane - Stifel Kevin McVeigh - UBS Elise Kenner - JP Morgan Gabriela Borges - Goldman Sachs Koji Ikeda - Bank of America Crispin Love - Piper Sandler Operator Good m ...

0 = HOWO TO �� wolford on ono a color of the order of on one on one of one . Enfusion 3Q 2024 T LE CONOMIC CONSULT OF OF TO THE OF TO TO TO TO TO Shareholder Letter · · · · · · · · · · · · · · 000000 0 November 2024 . . - 0 .. . . . . . . . . . . . . . . .. . . . . . . . . . . . . . . . . . . . t to the submit of the county of the county 000 000 000 - 0.0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . 0 . . . . . ... ¨·· ënfusion ©2024 ENFUSION. ALL RIGHTS RESERVED. Disclaimer 2 Forward-Looking Statements Statem ...

Enfusion, Inc. (ENFN) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.04 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -16.67%. A quarter ago, it was expected that this company would post earnings of $0.06 per share when it actually produced earnings of $0.05, delivering a surprise of -16.67%.Over the last four quarters, the company ...

Exhibit 99.1 . . . . . To o Top . . . . . ● -- ● ● ● . ······ 000 0 0 � ● ● ● November 2024 o o o o o o o o 0 · 0 · 0 · 0 · 0 ● ● 0 enfusion Enfusion 3Q 2024 . . Shareholder Letter · · · · · 0 0 0 Disclaimer Forward-Looking Statements Statements we make in this presentation may include statements which are not historical facts and are considered forward- looking within the meaning of Section 27A of the Securities Act of 1933 (Securities Act) and Section 21E of the Securities Exchange Act of 1934 (Exchange A ...

Enfusion, Inc. (ENFN) shares rallied 5% in the last trading session to close at $8.98. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 5.3% gain over the past four weeks. Enfusion is benefiting from robust client acquisition and successful expansion into institutional asset management markets. This company is expected to post quarterly earnings of $0.06 per share in its upcoming report, which represents a yea ...